Fredys Fernando Sanchez Hoyos

Mr. Fredys Fernando Sanchez Hoyos

University of Cartagena, Cartagena, Bolívar, Colombia
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Plants
Verified
Journal Article
Open access
PDF file
LCLeonor Cervantes Ceballos
Leonor Cervantes Ceballos
JSJorge Mario Sánchez-Hoyos
Jorge Mario Sánchez-Hoyos
FHFredys Fernando Sanchez Hoyos
Fredys Fernando Sanchez Hoyos
ENErick Manuel Torres Niño
Erick Manuel Torres Niño
JMJairo Enrique Mercado
Jairo Enrique Mercado
Harold GómezHarold Gómez
Harold Gómez
The genus Malachra L. belongs to the family Malvaceae. It includes herbs or subshrubs of nine accepted species with approximately thirty synonyms, and it has been widely used in community folk medicine to treat health problems including inflammation, nasal obstruction, leishmaniasis, malaria, childbirth, kidney disorders, fever, respiratory tract diseases, among others. From the genus Malachra L., flavonoids, steroids, triterpenes, anthocyanins, leucoanthocyanins, saponins, carbohydrates, phenols, glycosides, and alkaloids have been isolated and identified. Some pharmacological reports have indicated that the genus has antidiarrheal, antiepileptic, antiulcerogenic, antioxidant, anticonvulsant, antiviral, anticancer, antibacterial, anthelmintic, and hepatoprotective properties. However, there have been limited studies of bioactive molecules with pharmacological and biological activities associated with Malachra alceifolia Jacq., Malachra capitata (L.) L., Malachra fasciata Jacq., Malachra radiata (L.) L., Malachra ruderalis Gürke., Malachra rudis Benth., Malachra helodes Mart., Malachra urens Poit. ex Ledeb. & Alderstam., and Malachra officinalis Klotzsch. In this review, we consider the conservation of these species to save the ancestral knowledge of their traditional use in populations, and their pharmacological potential for future studies in search of alternatives for solutions to diseases in humans and animals and tools for the design and search of potential bioactive compounds against infectious and non-infectious agents.

1 May 2017 in Revista Colombiana de Ciencias Químico Farmacéuticas
Verified
Journal Article
Open access
LCLeonor Cervantes Ceballos
Leonor Cervantes Ceballos
FHFredys Fernando Sanchez Hoyos
Fredys Fernando Sanchez Hoyos
Harold GómezHarold Gómez
Harold Gómez
Cordia dendata Poir, Heliotropium indicum Linn y Momordica charantia Linn sonusadas para el tratamiento de las enfermedades más comunes y trastornos de salud enla medicina popular de la población de la costa norte de Colombia. En este estudiose investigó la composición química y la actividad antibacterial de los extractosetanólicos y fracciones de C. dentata, H. indicum y M. charantia. Los constituyentesquímicos se examinaron por detección cualitativa cromatografía de capa fina (TLC,por sus siglas en inglés). La actividad antibacterial se determinó por difusión en agary microdilución en caldo. Los mayores compuestos identificados fueron flavonoides,glucósidos cardiotónicos, alcaloides, saponinas, terpenoides, taninos y cumarinas.La concentración inhibitoria mínima (MIC, por sus siglas en inglés) fue de 31,25a 1.000 g/mL para bacterias Gram-positivas y Gram-negativas, respectivamente.Estos resultados indican que el extracto etanólico y las fracciones de C. dentata, H.indicum y M. charantia inhibieron de manera significa el crecimiento de las cepasestándar. La potente actividad antibacterial de C. dentata, H. indicum y M. charantiapuede considerarse en posteriores estudios, en particular frente a casos de antibióticosresistentes.

1 September 2016 in Revista Colombiana de Ciencias Químico Farmacéuticas
Verified
Journal Article
Open access
PDF file
FHFredys Fernando Sanchez Hoyos
Fredys Fernando Sanchez Hoyos
ACArgenis Cárdenas
Argenis Cárdenas
JMJairo Mercado-Camargo
Jairo Mercado-Camargo
GMGina Domínguez- Moré
Gina Domínguez- Moré
Harold GómezHarold Gómez
Harold Gómez
La metodología analítica para la cuantificación de warfarina sódica en tabletas de 5 mg fue estandarizada y validada mediante cromatografía líquida de alta eficiencia acoplada a detector de arreglo de diodo (HPLC-DAD). Se usó como fase móvil una mezcla compuesta por MeOH-AcOH-H2O (68:1:32), una columna cromatográfica C8e Phenomenex® de 150 x 4,6 mm y tamaño de partícula de 5 μm. Los resultados analíticos muestran que el método es preciso, exacto y selectivo para este fármaco. La curva de calibración se realizó en un intervalo del 80 al 120%, en una concentración nominal de 0,1mg/mL, demostrando ser lineal con un coeficiente de correlación a r2> 0,990; el porcentaje de recuperación fue de 98,1%±1,3, la precisión medida a través de la repetibilidad y la precisión intermedia fue adecuada (%RSD<2). En la prueba de disolución se encontró un porcentaje de 92,3% ± 3. Por lo tanto, la metodología desarrollada cumple con las especificaciones establecida por la USP 38/NF.

19 April 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMatías Levio
Matías Levio
FCFrancisco Rossel Carrera
Francisco Rossel Carrera
FHFredys Fernando Sanchez Hoyos
Fredys Fernando Sanchez Hoyos
MHMaycol Huerta
Maycol Huerta
CACarlos Alamos
Carlos Alamos
EAEyleen Araya
Eyleen Araya
Background/Objectives: Beta amyloid (Aβ) aggregates play a central role in the pathophysiology of Alzheimer’s disease (AD), and their detection and modulation remain major challenges in developing effective therapeutic and diagnostic strategies. Previously, gold nanoparticles with plasmonic and optical properties in the near-infrared (NIR) region and photothermal capabilities have been designed for detecting and disaggregating Aβ aggregates. However, these systems often face limitations related to biodegradability, long-term accumulation, and safety. In this work, a degradable NIR-responsive nanosystem based on small gold nanoparticles (sAuNPs), potentially excretable due to their small size, encapsulated within bovine serum albumin (BSA) and functionalized with the all-D peptide D3, was developed to inhibit Aβ aggregation. Methods: sAuNPs (~5–6 nm), functionalized with HS-PEG-NH2, were encapsulated into BSA nanoparticles using a desolvation method and subsequently conjugated to D3, resulting in the nanosystem f-sAuNPs-BSANPs-D3. The nanosystem was characterized by UV–Vis–NIR spectroscopy, dynamic light scattering, zeta potential analysis, electron microscopy, and nanoparticle tracking analysis. The effects of the nanosystem on Aβ1–42 aggregation were evaluated using a thioflavin T assay and electron microscopy. Additionally, the effects of f-sAuNPs-BSANPs-D3 on cell viability and its stability against trypsin digestion were assessed. Results: The nanosystem exhibited a measurable photothermal response under NIR irradiation and significantly reduced fibril formation. It did not affect the viability of SH-SY5Y neuronal cells at the tested concentrations. Trypsin incubation experiments demonstrated that the nanosystem remained stable at low enzyme concentrations mimicking plasma conditions, whereas higher enzyme concentrations induced degradation of the albumin matrix and subsequent disaggregation of sAuNPs. Conclusions: Overall, this study presents a degradable, albumin-based sAuNP nanosystem with NIR-responsive properties and potential for nanomedicine applications to inhibit Aβ aggregation in AD.

Verified
Journal Article
Open access
PDF file
PRPablo Reyes-Bazaez
Pablo Reyes-Bazaez
EZEwaldo Zavala
Ewaldo Zavala
FHFredys Fernando Sanchez Hoyos
Fredys Fernando Sanchez Hoyos
Orlando Donoso-GonzálezOrlando Donoso-González
Orlando Donoso-González
JMJavier Morales
Javier Morales
MKMarcelo Kogan
Marcelo Kogan
Background/Objectives: Morin is the first flavonoid isolated from plants in the Moraceae family and has been reported to exhibit anticancer and antioxidant activity. It is classified as a Class IV compound in the Biopharmaceutical Classification System due to its low water solubility and low permeability. This study aimed to develop and characterize morin-loaded liposomes composed of DPPC and cholesterol to improve their stability and anticancer activity. Methods: Liposomes were prepared by thin-film hydration and then processed by bath sonication, probe sonication, or membrane extrusion to control vesicle size. Formulations were characterized by hydrodynamic diameter, polydispersity index (PDI), zeta potential, encapsulation efficiency (EE), and colloidal stability over 7 days at 37 °C. The cytotoxic effects of free and encapsulated morin were evaluated in tumor (MDA-MB-231, B16F10) and non-tumor (NIH-3T3, HEK-293T) cell lines. Results: Extrusion yielded the most homogeneous liposomes (PDI = 0.2, size ≈ 90 nm), whereas sonication methods produced larger, more polydisperse vesicles. EE ranged from 11–17%, with no significant differences among methods. Free morin degraded by 40% at 37 °C after 7 days, whereas liposomal encapsulation significantly reduced degradation, preserving 82–89% of the compound. At a morin equivalent of 3.4 µM, the bath-sonicated formulation reduced viability to approximately 65% in MDA-MB-231 cells and 70% in B16F10 cells, whereas viability remained approximately 86% in NIH-3T3 cells and 82% in HEK-293T cells. All formulations maintained colloidal stability over the study period. In cytotoxicity assays, free morin showed minimal activity, whereas liposomal formulations significantly enhanced antiproliferative effects against cancer cells. Conclusions: These findings demonstrate that DPPC/cholesterol liposomes effectively stabilize morin and improve its bioactivity, representing a promising strategy for delivering this flavonoid in anticancer therapies.